Through a different mechanism, long-term chemotherapy may induce chemoresistance by upregulation of miR-92a-3p, and subsequent downregulation of ERCC2 and XRCC1 expression in colon cancer, promoting hypermutability and tumor heterogeneity. This evidence concerns the gene XRCC1 and neoplasm.